Antibody Response to SARS-CoV-2 in the First Batch of COVID-19 Patients in China by a Self-Developed Rapid IgM-IgG Test.
Front Cell Infect Microbiol
; 12: 915751, 2022.
Article
in En
| MEDLINE
| ID: mdl-35719335
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Front Cell Infect Microbiol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Suiza